Exhaled breath condensate acidification in acute lung injury  by Gessner, Christian et al.
Exhaled breath condensate acidification in acute
lung injury
Christian Gessnera,*, Stefan Hammerschmidta, Hartmut Kuhna,
Hans-J .urgen Seyfartha, Ulrich Sackb, Lothar Engelmanna,
Joachim Schauera, Hubert Wirtza
aDepartment of Internal Medicine, Pulmonary Medicine, Critical Care and Cardiology, University of
Leipzig, Johannisallee 32, Leipzig 04103, Germany
bInstitute of Clinical Immunology and Transfusion Medicine, University of Leipzig, Johannisallee 30,
Leipzig 04103, Germany
Summary Lung injury in ventilated lungs may occur due to local or systemic disease
and is usually caused by or accompanied by inflammatory processes. Recently,
acidification of exhaled breath condensate pH (EBC-pH) has been suggested as marker
of inflammation in airway disease. We investigated pH, ammonia, lactate, pCO2,
HCO3
, IL-6 and IL-8 in EBC of 35 ventilated patients (AECC-classification: ARDS: 15,
ALI: 12, no lung injury: 8).
EBC-pH was decreased in ventilated patients compared to volunteers (5.8570.32
vs. 7.4670.48; Po0:0001). NH4þ , lactate, HCO3, pCO2, IL-6 and IL-8 were analyzed in
EBC and correlated with EBC-pH. We observed correlations of EBC-pH with markers of
local (EBC IL-6: r ¼ 0:71; Po0:0001; EBC IL-8: r ¼ 0:68; Po0:0001) but not
of systemic inflammation (serum IL-6, serum IL-8) and with indices of severity of
lung injury (Murray’s Lung Injury Severity Score; r ¼ 0:73; Po0:0001; paO2/FiO2;
r ¼ 0:54; Po0:001). Among factors potentially contributing to pH of EBC, EBC-lactate
and EBC-NH4
þ were found to correlate with EBC-pH.
Inflammation-induced disturbances of regulatory mechanisms, such as glutaminase
systems may result in EBC acidification. EBC-pH is suggested to represent a marker of
acute lung injury caused by or accompanied by pulmonary inflammation.
r 2003 Elsevier Ltd. All rights reserved.
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Introduction
Exhaled breath condensate (EBC) is a novel
technique of sampling the lining fluid of the lung.1
EBC is obtained during exhalation into a cold trap.
Commercial devices are available and the method
can be adapted to mechanical ventilation by
inserting an appropriate conduit into the expiratory
limb of the ventilator tubing. Although mostly
water vapor, EBC contains other constituents such
as small molecules, proteins and even DNA.1 The
mechanisms that contribute to the presence of
non-volatile molecules in EBC have not yet been
elucidated but the formation of an aerosol during
reopening of alveoli or at the branching of small
airways is a likely mechanism. We have found that
the amount of breath condensate depends almost
exclusively on the expired volume.2 EBC has been
used for monitoring inflammatory airway diseases
such as asthma and COPD but also interstitial lung
disease and the acute respiratory distress syndrome
(ARDS).3 Investigations of EBC have focused
on H2O2,
4–6 8-isoprostanes,7–9 eicosanoids,10 and
cytokines.11
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Recently, a reduced pH of EBC (EBC-pH) was
demonstrated in acute asthma and this effect
was normalized following steroid therapy.12 The
authors proposed increased inflammation particu-
larly due to eosinophil mediators to be the cause of
this acidification of EBC. In a subsequent study they
suggested a pH regulatory role of glutaminase in
the human airway epithelium. Glutaminase might
liberate ammonia thereby buffering pH.13
EBC-pH was investigated in another group of
patients with airway diseases such as COPD,
bronchiectasis and asthma.14 The greatest de-
crease in EBC-pH was observed in patients with
bronchiectasis not currently using inhalative corti-
costeroids.
Several investigations have thus demonstrated
that EBC acidification may reflect airway inflam-
mation. We hypothesized that EBC acidification
may be a more general indicator of pulmonary
inflammation and/or injury and investigated the
usefulness of EBC-pH in mechanically ventilated
patients with acute inflammatory lung disease.
Methods
Study subjects and clinical scores
EBC was collected from 35 medical ICU patients.
Patients characteristics are depicted in Table 1.
Twelve of the 35 patients with pneumonia suffered
from a pre-existing chronic obstructive pulmonary
disease (COPD). Because we did not find significant
differences between patients with pneumonia
with and without COPD, data were not presented
for these subgroups. Patients were included after
24–72 h of ventilation. All patients were ventilated
using a Servo 300 (Siemens, Germany). Lung injury
in ventilated patients was estimated using the
criteria stated at the American–European Consen-
sus Conference on ARDS (AECC) 15 and the Murray’s
Lung Injury Severity Score (LISS),16 (Table 2). Lung
injury was estimated at the time of EBC collection.
General (in contrast to pulmonary) disease severity
was described by the APACHE II score.17
For comparison with the physiological situation,
EBC was also collected from twelve spontaneously
breathing, healthy, non-smoking volunteers
(5 male, 7 female, age: 57710).
Approval for this investigation was gained from
the ethics committee of the University of Leipzig.
EBC collection
EBC was collected by inserting a special conduit
(FILT Lung and Chest Diagnostics Ltd., Germany) for
the EcoScreens breath condensate collecting
device (Jaeger-Toennies, Germany) into the ex-
piratory limb of the ventilator tubing directly after
the Y-shaped connecting piece. EBC was collected
for a 30min time period. Humidification of inspira-
tory gas was achieved using identical heat humidi-
fiers.
EBC was similarly collected for 30min from
spontaneously breathing volunteers with the Eco-
Screens system as previously described.2
pH measurement
EBC-pH was measured at 101C immediately after
completion of the 30min collection period in a
blood gas analyzer (ABL 505, Radiometer, Den-
mark). pH measurement was repeated following
dearation of the condensate with argon for 10min
as described by Hunt et al.12 In addition to pH,
pCO2, HCO3
, sodium and potassium were analyzed
in EBC.
In 19 of the 35 patients pH was also measured in
the lingual bronchus using a small diameter pH
probe (Flexilog 2000, antimon single channel
catheter, Schwa-Medico, Germany). The probe
was inserted through the working channel of a
bronchoscope and positioned as closely to the
bronchial wall as possible in order to achieve good
contact with the airway lining fluid. Measurements
were taken before other interventions such as
bronchial lavages were performed.
Mediators and serum markers
All EBC samples were examined for amylase activity
(alpha-Amylase ESP1491300 kit; detection limit
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Table 1 Patients characteristics.
Patients characteristics
Total number 35
Male 17
Female 18
Age (years) 61715
Reason for intubation
(A) severe pneumonia (without
COPD-patients)
23
(B) COPD exacerbation (with
pneumonia)
12
Pre-existing chronic lung diseases
COPD (smokersn) 12 (8)
Non (smokersn) 23 (2)
nSmoking was defined as current smokers or ex-smokers
that discontinued smoking no longer than twelve months.
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0.05 mmol/l s; Boehringer Mannheim, Germany) in
order to exclude contamination by saliva.
Five milliliter aliquots of EBC were lyophilized,
reconstituted in 500 ml and used in IL-6, IL-8, and
TNF-a ELISA assays (Quantikine HS human IL-6,
QuantiGlo human IL-8, QuantiGlo human TNF-a;
R&D Systems, USA). Ammonia concentrations were
determined from 300 ml aliquots of native EBC by
ammonia test kit (No. 1877984, Roche Diagnostics
GmbH, Germany). EBC lactate was measured
by spectrometry using a routine lactate test kit
(No. 735, Sigma, Germany) at 540 nm.
In addition, IL-6, IL-8, TNF-a (Immulite, DPC
Biermann, Germany), and procalcitonin (LUMItest
PCT, BRAHMS Diagnostica, Germany) were mea-
sured from serum concomitantly.
Statistical analysis
Statistical analysis was performed with the SPSS
software package (SPSS Inc., Chicago, USA). Linear
regression analysis was performed to analyze the
correlation of EBC-pH with EBC markers, serum
markers, and clinical scores. Comparison of groups
were performed by ANOVA testing and post hoc
analysis (Bonferroni). Statistical significance was
accepted at the 5% level. Results are mean7SD.
Results
Amylase measurement and EBC diluting
factor
None of the samples of ventilated or spontaneously
breathing individuals exhibited amylase activity.
Mean values for EBC-sodium (8.54mmol/l70.9)
and EBC-potassium (0.13mmol/l70.06) did not
differ among spontaneously breathing healthy
volunteers and patients with ARDS, ALI, or without
lung injury. The dilution of ELF in EBC was
estimated using the equation described by Effros
et al.18 The resulting dilution factor ranged from
12.8 to 21.1 with a mean of 16.771.8. There were
no differences in the dilution factor among AECC as
well as LISS subgroups. In addition dilution factors
did not differ between healthy volunteers and
ventilated patients (healthy volunteers: 16.171.8,
ventilated patients: 16.771.8; P ¼ 0:3).
Methodical aspects of pH measurement
EBC-pH measured directly in ventilated patients
(5.8570.32) and measured after argon dearation
(5.9870.36) were closely correlated (r ¼ 0:89;
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Po0:0001). The standard deviation of repeated pH
measurements were within the error of the pH
probe (o10%).
EBC-pH, EBC-NH4
þ , and EBC-lactate in
spontaneously breathing volunteers and
ventilated patients
EBC-pH and EBC-NH4
þ in mechanically ventilated
patients were significantly decreased compared to
spontaneously breathing individuals (EBC-pH:
5.8570.32 vs. 7.4670.48; Po0:0001; EBC-NH4þ ;
EBC-NH4
þ : 26.5mmol/l716.4 vs. 222.8mmol/l7112.9;
Po0.0001).
In contrast, EBC-lactate was significantly higher
in ventilated patients (0.45 mmol/l70.3) compared
to spontaneously breathing volunteers (0.13 mmol/
l70.09; Po0:001).
EBC-pH, EBC-NH4
þ , and EBC-lactate and
severity of lung injury
Figure 1 summarizes EBC-pH, EBC-NH4
þ , and EBC-
lactate in ventilated patients grouped according to
both AECC as well as LISS criteria. EBC-pH and EBC-
NH4
þ were found to be decreased in patients
with more injured lungs while EBC-lactate was
increased.
EBC-pH was closely correlated with EBC-NH4
þ
(r ¼ 0:52; Po0:001) and inversely correlated with
EBC-lactate (r ¼ 0:53; Po0:001).
Bicarbonate, pCO2, and EBC-pH
A correlation of EBC-pH existed with EBC-pCO2
(r ¼ 0:57; Po0:0001) and EBC-HCO3 (r ¼ 0:54;
Po0:001). However, all three of these EBC para-
meters were not correlated with equivalent para-
meters in arterial blood.
Correlation of EBC-pH and pH of bronchial
ELF
Bronchial ELF-pH determined in the lingual lobe
bronchus in a subgroup of 19 patients did not
exhibit a similar reduction in pH (bronchial pH:
7.0470.44; EBC-pH: 5.7670.29) and was only
weakly and not significantly correlated with EBC-
pH (r ¼ 0:4; P ¼ 0:08).
Pro-inflammatory cytokines and EBC-pH
IL-6 was detectable in EBC of 28 ventilated patients
(85.1%). IL-6 was not detected in EBC from four
patients without lung injury, two patient with ALI
and one patient with ARDS according to the AECC
classification. EBC IL-6 correlated inversely with
EBC-pH (r ¼ 0:71; Po0:0001; Fig. 2a).
IL-8 was detected in EBC of 23 ventilated
patients (74.5%). IL-8 was not detected in EBC
from seven patients without lung injury, four
patients with ALI and one patients with ARDS
according to AECC classification. Similarly to EBC
IL-6, EBC IL-8 correlated inversely with EBC-pH
(r ¼ 0:68; Po0:0001; Fig. 2b).
In contrast, EBC-pH did not correlate with IL-6 or
IL-8 in serum. TNF-a was not measurable in EBC. TNF-
a was not measurable in EBC. The most likely reason
for the non-detection of TNF-a in EBC was insufficient
sensitivity (detection limit: 0.28pg/ml) of the assay
at low TNF-a levels. TNF-a levels, however, were
measurable in serum. Both serum TNF-a and serum
PCTwere not correlated with EBC-pH.
EBC-pH and scores of lung injury and disease
severity
EBC-pH was inversely correlated with specific lung
injury scores determined at the time of breath
condensate collection. Correlation of EBC-pH and
paO2/FiO2 ratio was r ¼ 0:54 (Po0:001; Fig. 3a) and
of EBC-pH and LISS r ¼ 0:73 (Po0:0001; Fig. 3b).
In contrast to these lung specific scores, EBC-pH did
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Figure 1 EBC-pH, EBC-NH4
þ , and EBC-lactate concen-
trations in lung disease severity subgroups according to
the AECC and LISS classifications (Table 2).
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not correlate with a more generalized and widely
used indicator of disease severity, the APACHE II
score (r ¼ 0:14; P ¼ 0:42). Similarly, EBC-NH4
þ
was not correlated with the APACHE II score
(r ¼ 0:2; P ¼ 0:25).
In contrast to EBC-pH, both EBC-NH4
þ and EBC-
lactate were not observed to correlate with paO2/
FiO2 or LISS.
Discussion
In this study we report findings of an investigation
of exhaled breath condensate pH (EBC-pH) in
ventilated patients with and without signs of ALI
or ARDS according to the AECC classification or LISS.
The main findings were (i) a decreased EBC-pH, i.e.
an acidification in EBC, accompanied by decreased
ammonia and increased lactate in EBC in all
ventilated patients in comparison with a control
group of spontaneously breathing healthy volun-
teers, (ii) a close relation of exhaled breath
condensate acidification and the extent of lung
injury, (iii) an inverse correlation of EBC-pH with
concentrations of pro-inflammatory cytokines in
EBC but not in serum. The later findings suggest
that a lower EBC-pH indicates inflammatory lung
injury.
Amylase activity was not detectable in this study
both in spontaneously breathing volunteers as well
as in ventilated patients using an enzymatic assay.
Although saliva contamination in spontaneously
breathing individuals cannot be entirely excluded
without the use of mass spectrometry, a relevant
contamination may be ruled out. In fact, contam-
ination is almost avoided due to intubation in
ventilated patients. At the same time no differ-
ences in EBC sodium, potassium and dilution factors
were found between spontaneously breathing
volunteers and ventilated patients. This indicates
that EBC of spontaneously breathing volunteers and
ventilated patients may indeed be comparable.
Differences between volunteers and ventilated
patients therefore should not be due to saliva
contamination or differences in dilution factors.
This line of reasoning also argues against a
significant influence of exogenous humidification
on EBC parameters.
An important and as of yet unexplained result of
our study was the remarkable difference in EBC-pH
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Figure 2 Correlation of (A) EBC IL-6 and (B) EBC IL-8
with EBC-pH in patients exhibiting ARDS criteria (circles),
ALI criteria (squares), no signs of acute lung injury
(triangles; AECC subgroups).
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between spontaneously breathing volunteers
(7.4670.48) and ventilated patients (5.8770.31)
which exceeds the differences found in disease
severity subgroups of ventilated patients. This
difference may be explained by (i) differences
between healthy and injured lungs, (ii) differences
between spontaneous breathing and mechanical
ventilation or (iii) both. Hunt et al.12 reported a
mean EBC-pH of 7.6570.20 in spontaneously
breathing control subjects, which is comparable
to our findings. In acute asthma they found a
decreased mean EBC-pH of 5.2370.21. Thus the
extent of EBC acidification in asthma in sponta-
neously breathing patients exceeded that observed
in our study in ventilated patients with various
degrees of inflammatory lung disease leading to
acute lung injury. Although we cannot from
our data estimate the effect of intubation and
ventilation on EBC-pH the study of Hunt et al.
demonstrates that the spectrum of EBC-pH in non-
ventilated patients encomprises the spectrum
observed in our study.
The subgroup analysis for lung injury severity
revealed that the greatest changes of EBC-pH, EBC-
lactate and EBC-NH4
þ occurred in the group of
patients with the greatest extent of lung injury.
This observation is strengthened by the correlation
of EBC-pH and clinical scores of lung injury (both
LISS and AECC score). These findings support EBC-
pH to be a marker of lung injury. However, lung
injury may be caused by a variety of reasons and
may be due to pulmonary inflammation or else
occur in response to systemic disorders which are
usually also inflammatory in a broader sense.
Because EBC acidification correlates well with
inflammatory cytokines in the very material which
is used for pH measurement such as EBC-IL6 and
EBC-IL8 we propose EBC-pH to be a marker of
pulmonary inflammatory lung injury. A correlation
of EBC-pH and serum IL-6 and IL8 as well as PCT in
serum would in this case not be expected and
indeed was not observed in this study. EBC-pH may
therefore, similar to the situation in acute asthma,
be the consequence of a local (pulmonary and/or
airway) inflammation of such an extent, that lung
injury occurs.
What are the mechanisms in acute inflammatory
lung injury leading to EBC acidification? Several
mechanisms may be envisioned that could disturb
the local pH homeostasis: (i) The lung is highly
dependent on glucose for both energy demand as
well as phospholipid synthesis. Aerobic as well as
anaerobic glucose utilization takes place in alveolar
epithelial cells.19 In hypoxia, continuing glucose
utilization for energy demands will result in
increased lactate production. However, lactate
generation of the lung in acute lung injury is
complex, but the lung has been recognized to be a
major source of lactate production. Lactate flux was
found to correlate with LISS in a study determining
the arterial–venous lactate differences in acute lung
injury.20 In our ventilated patients lactate levels
were generally elevated compared with those in
healthy volunteers and were more increased in
patients with higher lung injury scores (Fig. 1).
Increased pulmonary lactate release is therefore
likely to contribute to EBC acidification. (ii) A
mechanism that may counteract airway acidification
was recently suggested by Hunt et al.13: secretion of
ammonia due to glutaminase activity generating
glutamate from glutamine. Glutaminase has been
demonstrated in bronchial epithelial cells as well as
in the AT II cell derived A549 cell line. Inflammatory
cytokines inhibit glutaminase resulting in the inhibi-
tion of alkalinization and promotion of acidifica-
tion.13 The authors reported low levels of EBC-
ammonia in acute asthma (median 30mM) versus
controls (median 327mM) comparable to the differ-
ences observed in acute lung injury versus volun-
teers in our study.13 EBC-acidification may therefore
be due to essentially two mechanisms: pulmonary
lactate production and a reduced local buffer
capacity (i.e. ammonia).
pH in the larger airways in our hands did not
correlate with EBC-pH in a subset of 19 patients in
whom both measurements were performed. The
two measurements were performed by different
devices, but both devices were calibrated before
use and calibration solutions resulted in very similar
results. Although the generation of an aerosol in
distal airways or alveoli has been suggested to be a
likely mechanisms,1 breath condensate generation
is not completely understood. The compartmenta-
lization of lung injury may explain the differences in
pH values of EBC (distal lung) and the lining fluid in
central large airways.
We conclude that EBC-pH may reflect the extent
of acute lung injury and because it correlates with
proinflammatory cytokines locallyFbut not sys-
temicallyFthis injury is likely to be caused by or
accompanied by pulmonary inflammatory pro-
cesses. Because EBC-pH measurement is rapid and
does not require extensive instrumentation it may
be useful for both the estimation of the actual
extent of acute lung injury as well as a repetitive
monitoring parameter in ventilated patients.
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